Antisense & RNAi Therapeutics Market Report 2026
Download Free Sample Buy Now
Antisense & RNAi Therapeutics Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Antisense & RNAi Therapeutics Market Report 2026

Global Outlook – By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), By Indication (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Antisense & RNAi Therapeutics Market Overview

• Antisense & RNAi Therapeutics market size has reached to $1.93 billion in 2025

• Expected to grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%

• Growth Driver: Emerging Demand Antisense & RNAI Therapeutics For Neurodegenerative Disorders And Infectious Diseases

• Market Trend: Strategic Collaborations Driving Innovation In The Antisense & RNAI Therapeutics Market

• North America was the largest region in 2025.

What Is Covered Under Antisense & RNAi Therapeutics Market?

Antisense therapy refers to the selective, sequence-specific suppression of gene expression by single-stranded DNA oligonucleotides. Contrarily, RNA interference (RNAi) is activated by double-stranded RNA (dsRNA) and results in the sequence-specific mRNA degradation of single-stranded target RNAs.

The main technologies of antisense & RNAi therapeutics are RNA interference and antisense RNA. RNA interference is a conserved biological response to double-stranded RNA that mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids and regulates protein-coding gene expression. The various routes of administration include pulmonary delivery, intravenous injections, intra-dermal injections, intraperitoneal injections, topical delivery, and other delivery methods that are used for the indication of oncology, cardiovascular diseases (CVDs), respiratory disorders, neurological disorders, infectious diseases, other.

Antisense & RNAi Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Antisense & RNAi Therapeutics Market Size and Share 2026?

The antisense & rnai therapeutics market size has grown rapidly in recent years. It will grow from $1.93 billion in 2025 to $2.17 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to early adoption of antisense therapies, initial rnai research breakthroughs, development of oligonucleotide synthesis techniques, growing demand for targeted therapeutics, investments in biotech research.

What Is The Antisense & RNAi Therapeutics Market Growth Forecast?

The antisense & rnai therapeutics market size is expected to see rapid growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to advancements in delivery technologies, expansion of precision medicine, integration with ai-driven drug discovery, increasing rnai-based clinical trials, rising healthcare investments in emerging markets. Major trends in the forecast period include targeted gene silencing, novel delivery mechanisms, personalized therapeutics, nucleic acid stabilization techniques, regulatory & clinical advancements.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Antisense & RNAi Therapeutics Market Segmentation

1) By Technology: RNA Interference, Antisense RNA

2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods

3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications

Subsegments:

1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics

2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides

What Is The Driver Of The Antisense & RNAi Therapeutics Market?

The rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases is projected to contribute to the demand for the antisense & RNAi therapeutics market. Gene suppression approaches including RNA interference and antisense oligonucleotides are used for the treatment of various neurodegenerative conditions by repairing mutant genes. For instance, in January 2024, according to the report published by the American Heart Association, a US-based organization, the age-adjusted death rate from cardiovascular diseases increased to 233.3 per 100,000, reflecting a 4.0% rise from the previous year. Hence, the growing prevalence of several neurodegenerative diseases and infectious diseases is expected to drive the growth of the antisense & RNAi therapeutics industry.

Key Players In The Global Antisense & RNAi Therapeutics Market

Major companies operating in the antisense & rnai therapeutics market are Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen Ilaç ve Saglik Ürünleri A.S., Egypt Otsuka Pharmaceutical

Global Antisense & RNAi Therapeutics Market Trends and Insights

Major companies operating in the antisense & RNAi therapeutics market are undertaking strategic initiatives, such as collaborations and partnerships to sustain in the increasingly competitive market. Strategic collaboration is a business strategy that involves two or more companies working together to achieve a common goal or objective. For instance, in January 2023, Orbit Discovery Limited, a US-based company offering services for the discovery of peptides, partnered with SanegeneBio Inc., a UK-based company involved in the developing novel RNAi-based medicines for the identification of tissue-specific delivery of RNA therapeutics for efficient gene knockdown, aiming to develop a portfolio of advanced RNAi therapeutics. The collaboration encompasses hit identification and cell-based internalization studies, with Sanegene having the option to further develop the hits derived from the screening activities, leveraging Orbit's proprietary technology for rapid peptide lead discovery. Orbit Discovery's unique peptide display engine enables the screening of large peptide libraries, offering faster discovery times for relevant peptide leads based on affinity and functional screens.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market?

In July 2023, Alnylam, a US-based biopharmaceutical company that specializes in RNAi therapeutics, announced a strategic partnership with Roche AG to co-develop and co-commercialize Zilebesiran, an investigational RNAi therapeutic for the treatment of hypertension in patients with high cardiovascular risk. This collaboration combines Alnylam's expertise in RNAi therapeutics with Roche's extensive experience in drug development and commercialization, potentially transforming treatment options for patients with hypertension and high cardiovascular risk. Roche AG is a Switzerland-based pharmaceutical company that specializes in therapeutic treatment of cardiovascular diseases.

Regional Insights

North America was the largest region in the antisense & RNAi therapeutics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antisense & RNAi Therapeutics Market?

The antisense and RNAi therapeutics market includes revenues earned by entities by regulating gene expression at multiple levels, such as replication, transcription, and translation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antisense & RNAi Therapeutics Market Report 2026?

The antisense & rnai therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antisense & rnai therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Antisense & RNAi Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.17 billion
Revenue Forecast In 2035 $3.53 billion
Growth Rate CAGR of 12.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Technology, Route Of Administration, Indication
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., S
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Antisense & RNAi Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Antisense & RNAi Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Antisense & RNAi Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Antisense & RNAi Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Targeted Gene Silencing

4.2.2 Novel Delivery Mechanisms

4.2.3 Personalized Therapeutics

4.2.4 Nucleic Acid Stabilization Techniques

4.2.5 Regulatory & Clinical Advancements

5. Antisense & RNAi Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals & Clinics

5.2 Pharmaceutical & Biotech Companies

5.3 Research Laboratories

5.4 Academic & Medical Institutes

5.5 Contract Research Organizations (Cros)

6. Antisense & RNAi Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Antisense & RNAi Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Antisense & RNAi Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Antisense & RNAi Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Antisense & RNAi Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Antisense & RNAi Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Antisense & RNAi Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Antisense & RNAi Therapeutics Market Segmentation

9.1. Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

RNA Interference, Antisense RNA

9.2. Global Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous Injections, Intra-dermal Injections, Other Delivery Methods

9.3. Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications

9.4. Global Antisense & RNAi Therapeutics Market, Sub-Segmentation Of RNA Interference (RNAi), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics

9.5. Global Antisense & RNAi Therapeutics Market, Sub-Segmentation Of Antisense RNA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides

10. Antisense & RNAi Therapeutics Market Regional And Country Analysis

10.1. Global Antisense & RNAi Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Antisense & RNAi Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Antisense & RNAi Therapeutics Market

11.1. Asia-Pacific Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Antisense & RNAi Therapeutics Market

12.1. China Antisense & RNAi Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Antisense & RNAi Therapeutics Market

13.1. India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Antisense & RNAi Therapeutics Market

14.1. Japan Antisense & RNAi Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Antisense & RNAi Therapeutics Market

15.1. Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Antisense & RNAi Therapeutics Market

16.1. Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Antisense & RNAi Therapeutics Market

17.1. South Korea Antisense & RNAi Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Antisense & RNAi Therapeutics Market

18.1. Taiwan Antisense & RNAi Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Antisense & RNAi Therapeutics Market

19.1. South East Asia Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Antisense & RNAi Therapeutics Market

20.1. Western Europe Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Antisense & RNAi Therapeutics Market

21.1. UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Antisense & RNAi Therapeutics Market

22.1. Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Antisense & RNAi Therapeutics Market

23.1. France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Antisense & RNAi Therapeutics Market

24.1. Italy Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Antisense & RNAi Therapeutics Market

25.1. Spain Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Antisense & RNAi Therapeutics Market

26.1. Eastern Europe Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Antisense & RNAi Therapeutics Market

27.1. Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Antisense & RNAi Therapeutics Market

28.1. North America Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Antisense & RNAi Therapeutics Market

29.1. USA Antisense & RNAi Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Antisense & RNAi Therapeutics Market

30.1. Canada Antisense & RNAi Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Antisense & RNAi Therapeutics Market

31.1. South America Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Antisense & RNAi Therapeutics Market

32.1. Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Antisense & RNAi Therapeutics Market

33.1. Middle East Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Antisense & RNAi Therapeutics Market

34.1. Africa Antisense & RNAi Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Antisense & RNAi Therapeutics Market Regulatory and Investment Landscape

36. Antisense & RNAi Therapeutics Market Competitive Landscape And Company Profiles

36.1. Antisense & RNAi Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Antisense & RNAi Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Antisense & RNAi Therapeutics Market Company Profiles

36.3.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Ionis Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Alnylam Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Arrowhead Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Antisense & RNAi Therapeutics Market Other Major And Innovative Companies

Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics

38. Global Antisense & RNAi Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market

40. Antisense & RNAi Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Antisense & RNAi Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Antisense & RNAi Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Antisense & RNAi Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Antisense & RNAi Therapeutics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Antisense & RNAi Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Antisense & RNAi Therapeutics Market, Supply Chain Analysis
  • Table 4: Global Antisense & RNAi Therapeutics Market, Major Raw Material Providers
  • Table 5: Global Antisense & RNAi Therapeutics Market, Major Resource Providers
  • Table 6: Global Antisense & RNAi Therapeutics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Antisense & RNAi Therapeutics Market, Major Distributors And Channel Partners
  • Table 8: Global Antisense & RNAi Therapeutics Market, Key Technologies & Future Trends
  • Table 9: Global Antisense & RNAi Therapeutics Market, Major Trends
  • Table 10: Global Antisense & RNAi Therapeutics Market, Major End Users
  • Table 11: Global Antisense & RNAi Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Antisense & RNAi Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Antisense & RNAi Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Antisense & RNAi Therapeutics Market - TAM, US$ Billion, 2025
  • Table 15: Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Antisense & RNAi Therapeutics Market, Sub-Segmentation Of RNA Interference (RNAi), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Antisense & RNAi Therapeutics Market, Sub-Segmentation Of Antisense RNA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Antisense & RNAi Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Antisense & RNAi Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Antisense & RNAi Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Antisense & RNAi Therapeutics Market - Company Scoring Matrix
  • Table 96: Biogen Inc. Financial Performance
  • Table 97: Ionis Pharmaceuticals Inc. Financial Performance
  • Table 98: Alnylam Pharmaceuticals Inc. Financial Performance
  • Table 99: Arrowhead Pharmaceuticals Inc. Financial Performance
  • Table 100: Moderna Inc. Financial Performance
  • Table 101: Global Antisense & RNAi Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Antisense & RNAi Therapeutics Market, Competitive Dashboard
  • Table 103: Global Antisense & RNAi Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Antisense & RNAi Therapeutics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 105: Global, Antisense & RNAi Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 106: Global, Antisense & RNAi Therapeutics Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Antisense & RNAi Therapeutics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Antisense & RNAi Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Antisense & RNAi Therapeutics Market, Supply Chain Analysis
  • Figure 4: Global Antisense & RNAi Therapeutics Market, Major Raw Material Providers
  • Figure 5: Global Antisense & RNAi Therapeutics Market, Major Resource Providers
  • Figure 6: Global Antisense & RNAi Therapeutics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Antisense & RNAi Therapeutics Market, Major Distributors And Channel Partners
  • Figure 8: Global Antisense & RNAi Therapeutics Market, Key Technologies & Future Trends
  • Figure 9: Global Antisense & RNAi Therapeutics Market, Major Trends
  • Figure 10: Global Antisense & RNAi Therapeutics Market, Major End Users
  • Figure 11: Global Antisense & RNAi Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Antisense & RNAi Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Antisense & RNAi Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Antisense & RNAi Therapeutics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Antisense & RNAi Therapeutics Market, Sub-Segmentation Of RNA Interference (RNAi), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Antisense & RNAi Therapeutics Market, Sub-Segmentation Of Antisense RNA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Antisense & RNAi Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Antisense & RNAi Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Antisense & RNAi Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Antisense & RNAi Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Antisense & RNAi Therapeutics Market - Company Scoring Matrix
  • Figure 96: Biogen Inc. Financial Performance
  • Figure 97: Ionis Pharmaceuticals Inc. Financial Performance
  • Figure 98: Alnylam Pharmaceuticals Inc. Financial Performance
  • Figure 99: Arrowhead Pharmaceuticals Inc. Financial Performance
  • Figure 100: Moderna Inc. Financial Performance
  • Figure 101: Global Antisense & RNAi Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Antisense & RNAi Therapeutics Market, Competitive Dashboard
  • Figure 103: Global Antisense & RNAi Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Antisense & RNAi Therapeutics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 105: Global, Antisense & RNAi Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 106: Global, Antisense & RNAi Therapeutics Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Read More About Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Read More About Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Read More About Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Antisense & RNAi Therapeutics Market Report 2026 - Global Outlook – By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), B...

Clinical Chemistry Analyzers Market Report 2026 - Global Outlook – By Product (Clinical Chemistry Analyzers, Clinical Chemistry Reagents, Other Products), By Analyzer Technology (Semi-Automated Clinical Chemistry Analyze...

Antivirals Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes )...

Biochips Market Report 2026 - Global Outlook – By Type (Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays), By Technology (Microarrays, Microfluidics), By Application (Drug Discove...

Frequently Asked Questions

The Antisense & RNAi Therapeutics Market Report 2026 market was valued at $1.93 billion in 2025, increased to $2.17 billion in 2026, and is projected to reach $3.53 billion by 2030. request a sample here

The expected CAGR for the Antisense & RNAi Therapeutics Market Report 2026 market during the forecast period 2025–2030 is 12.9%. request a sample here

Major growth driver of the market includes: Emerging Demand Antisense & RNAI Therapeutics For Neurodegenerative Disorders And Infectious Diseases in the Antisense & RNAi Therapeutics Market Report 2026 market. For further insights on this market, request a sample here

The antisense & rnai therapeutics market covered in this report is segmented –
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics
2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides request a sample here

Major trend in this market includes: Strategic Collaborations Driving Innovation In The Antisense & RNAI Therapeutics Market For further insights on this market, request a sample here.

Major companies operating in the Antisense & RNAi Therapeutics Market Report 2026 market are Major companies operating in the antisense & rnai therapeutics market are Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Phar request a sample here.

North America was the largest region in the antisense & RNAi therapeutics market in 2025. The regions covered in the antisense & rnai therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us